Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kuehn BM – The FDA has had the authority to disqualify or remove from FDA–regulated trials any clinical investigators who have "repeatedly or deliberately" ignored regulations designed to protect human research participants or who have repeatedly or deliberately submitted false information to the agency or the sponsor of their research.

Related Articles

Increase in Quality, but Not Quantity, of Clinical Trials in Acute Pain: 1992 Versus 2007
Anesthesia & Analgesia, 10/21/09    Relevance Score: 69%

Cytokinetics Announces Advancement of CK-2017357 in Phase I Clinical Trials
Cytokinetics, 11/10/09    Relevance Score: 68%

Methodological aspects of lung cancer clinical trials in the era of targeted agents
Lung Cancer, 11/03/09    Relevance Score: 68%

Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
Boston Scientific, 10/06/09    Relevance Score: 68%

Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Cancer Chemotherapy and Pharmacology, 10/05/09    Relevance Score: 68%

Today in Epidemiology...keeping you current

Neglected tropical diseases
British Medical Bulletin, 12/11/09

Prevalence of Down Syndrome Among Children and Adolescents in 10 Regions of the United States
Pediatrics, 12/11/09

Health-related quality-of-life profiles in nonalexithymic and alexithymic subjects from general population
Journal of Psychosomatic Research, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address